Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Assurant is an appliance protection program with low deductibles and a short waiting period. Assurant’s plans cover a variety of home appliances, and you can create coverage based on your ...